Back to ACAD
Krensavage Asset Management, LLC → ACAD
Krensavage Asset Management, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
1
Latest value
$806K
Q3 2026
Peak value
$806K
First seen
Q3 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $806K | 40.0K | — | — |
Other funds holding ACAD
$954.9M
$864.7M
$386.3M
$383.2M
$377M
$323.1M